Description

Novox (levofloxacin) Coated Tablets 750 mg. №5

Ingredients

Active ingredient: Levofloxacin 750 mg.
Other ingredients: Microcrystalline cellulose, crospovidone, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol.

Dosage

Dosage: The usual dose is 750 mg once daily. Consult your healthcare provider for the correct dosage based on your condition.

Indications

Indications: Novox (levofloxacin) is indicated for the treatment of bacterial infections such as respiratory tract infections, skin and soft tissue infections, and urinary tract infections.

Contraindications

Contraindications: Do not use Novox (levofloxacin) if you have a history of tendon problems related to fluoroquinolone use or if you are allergic to levofloxacin or other fluoroquinolones.

Directions

Directions: Take Novox (levofloxacin) as directed by your healthcare provider. Do not crush or chew the tablets. Swallow the tablet whole with a full glass of water.

Scientific Evidence

Scientific evidence: Studies have shown that levofloxacin, the active ingredient in Novox, is effective in treating a wide range of bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the efficacy of levofloxacin in treating respiratory infections.

Additional Information

Storage: Store Novox (levofloxacin) tablets at room temperature away from moisture and heat.

Pregnancy and breastfeeding: Consult your healthcare provider before taking Novox if you are pregnant or breastfeeding.

Levofloxacin, the active ingredient in Novox tablets, belongs to the fluoroquinolone class of antibiotics. It works by inhibiting the bacterial DNA gyrase enzyme, thereby preventing DNA replication and ultimately leading to bacterial cell death. This mechanism of action makes levofloxacin effective against a broad spectrum of bacteria.

Clinical trials have shown that Novox (levofloxacin) tablets are comparable in efficacy to other fluoroquinolones in the treatment of various infections. A study published in the International Journal of Infectious Diseases compared the effectiveness of levofloxacin with ciprofloxacin and found similar cure rates in patients with urinary tract infections.